Frozen Blastocyst Transfer in Natural Cycle

Infertility Clinical Trial

Official title:

Cryopreserved Thawed Blastocyst Transfer in Natural Cycle With or Without hCG Administration

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01892826
• Other study ID #: TC8851
• Status: Completed
• Phase: N/A
• First received: July 1, 2013
• Last updated: July 3, 2013
• Start date: February 2009
• Est. completion date: March 2013

Study information

• Verified date: July 2013
• Source: Universitair Ziekenhuis Brussel
• Contact: n/a
• Is FDA regulated: No
• Health authority: Belgium: Institutional Review Board
• Study type: Interventional

Clinical Trial Summary

The rational of the study is to assess the pregnancy rate after the transfer of frozen blastocyst in natural cycle controlled by external administration of hCG.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 120
• Est. completion date: March 2013
• Est. primary completion date: February 2012
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 17 Years to 40 Years

Eligibility

Inclusion Criteria:

• age < 40

• BMI:18-29 kg/m2

• day 5 frozen embryo

• previously IVF/ICSI

Exclusion Criteria:

• OOCYTE DONATION CYCLES

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Infertility

Intervention

Drug:
• hCG
5000IU

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Universitair Ziekenhuis Brussel

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Implantation rate		2 years	Yes
Secondary	ongoing pregnancy rate		2 years	Yes